ValiRx plc (LON:VAL)
0.20p
Spriggl Score: Moderate— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict
“Deep distress signals across leverage and cash burn threaten total loss for shareholders.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About ValiRx plc
ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company develops VAL201, a short peptide that has completed Phase I/II trials for the treatment of prostate cancer; and VAL401, a refo…
- Sector:
- Healthcare
- Industry:
- Biotechnology
- Market Cap:
- £1.5M
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on ValiRx plc and 1,600+ UK and US stocks.
Start free